Evaluating the Correlation between PD-L1 Antibody Radiotracers and PD-1/PD-L1 Expression in Non-Small-Cell Lung Cancer: A Meta-Analysis
Journal of Medicine and Life Sciences · 2025
DOI: 10.71222/czsmm264 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Medicine and Life Sciences, 2025. Verfasst von Yihansheng Chen.
Abstract (Originalsprache)
Non-small-cell lung cancer (NSCLC) accounts for the majority of lung cancer cases, with PD-1/PD-L1 immune checkpoint inhibitors playing a crucial role in treatment. Accurate assessment of PD-L1 expression is essential for patient stratification, yet traditional biopsies are limited by tumor heterogeneity. This meta-analysis evaluates the correlation between PD-L1 antibody radiotracers and PD-1/PD-L1 expression in NSCLC patients using PET/CT and SPECT/CT imaging. Analysis of four clinical trials involving 50 patients and six NSCLC samples revealed that higher SUVmax and T:BP ratios correlated with PD-L1 expression and prognosis, offering a more comprehensive and non-invasive alternative to biopsies. While promising, standardization of imaging parameters and further validation in diverse patient populations are needed to refine clinical application.
Zitieren
APA
Chen, Y. (2025). Evaluating the Correlation between PD-L1 Antibody Radiotracers and PD-1/PD-L1 Expression in Non-Small-Cell Lung Cancer: A Meta-Analysis. Journal of Medicine and Life Sciences. https://doi.org/10.71222/czsmm264
Vancouver
Chen Y. Evaluating the Correlation between PD-L1 Antibody Radiotracers and PD-1/PD-L1 Expression in Non-Small-Cell Lung Cancer: A Meta-Analysis. Journal of Medicine and Life Sciences. 2025. doi:10.71222/czsmm264
BibTeX
@article{Chen2025,
author = {Chen, Yihansheng},
title = {Evaluating the Correlation between PD-L1 Antibody Radiotracers and PD-1/PD-L1 Expression in Non-Small-Cell Lung Cancer: A Meta-Analysis},
journal = {Journal of Medicine and Life Sciences},
year = {2025},
doi = {10.71222/czsmm264}
}
EUVIMED